Treating Viral Infections: What’s To Be Done?
[ed note: Michael Jorrin, who I dubbed “Doc Gumshoe,” is a longtime medical writer (not a doctor) who shares his thoughts with Gumshoe readers a couple times a month. He usually does not specifically cover investment ideas, and his words and opinions are his own — his past columns can be found here] Lots of […]
Comments
There is at least one trial already underway to see if antiviral medication can help with Alzheimer's, given the discove...
$$CYDY VANCOUVER, Washington, Feb. 20, 2018 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB:CYDY) reports the successful achiev...
Michael - for your flu article, look at Rapivab, the only IV flu antiviral approved for use in the ICU. Lots of children...
$Casey & ER, your post should be required reading for Gummies AND potential ER docs. I know from friends that this flu h...
Zimmy.....yes absolutely, and likely by recruitment of TLR's as well (Toll like receptors, ever sniffing for nucleic aci...
$THIS and $THAT $WEED.TO, $POT, $MJ $TRPX np :) Abstract: Cannabinoid receptors type 1 (CB1) and type 2 (CB2) ha...
$CWBR $Antiviral $Mitochondria dysfunction Hi, Belgiumchocolate: A couple of recent (2017) medical papers may he...
$CWBR $COB.U , FP Hi fellow Gummies, I was doing some DD this weekend and here is just a thought I wanted to share...
$ABVX - Evotec and ABIVAX enter into strategic collaboration to develop novel antiviral agents https://www.evotec.com/a...
$RGLS - of interest is language in the 8-K that expands on the problems associated with the clinical hold on RG- 101 and...
Sorry, yes it is ABX-464. Other than parking in the stock, which I have done, I have to admit I don't have a sense of cl...
$CYDY abstract Abstract Title: Interim Results of PRO 140 in a Phase 2b/3 Study in Treatment-Experienced HIV-1 Patients...
$ABVX Has anyone commented on this alternative explanation for the ABIVAX HIV viral reservoir effect: "The explana...
Redsox/Peter: To continue musing about Abivax, let me make what I think is an important point. In the early days of t...
$noticker Dr. Julius Youngner, Polio Vaccine Pioneer, Dies at 96 "Dr. Youngner was the last surviving member of the or...
$ABVX full link in English: http://www.abivax.com/en/news-events/press-releases/479-first-ever-evidence-of-treatment-in...
I'm not coming down on you, but I gotta say I am just shocked that you would seriously wield an "analysis" of ContraVir ...
12-Apr-2017:06:07:00, Novan Reports Positive Topline Results with SB208 in Phase 2 TrialClinical Evidence of Antifungal ...
I have a small position in Abivax. An article published in Retrovirology, 2015, presented an alternative explanation for...
New evidence of an increasingly bulked up, entrained and sophisticated biotech industry in Taiwan, long with the scienti...
If you like Nano-particles....there are many places to invest . NanoViricides, Inc. (NNVC) is using them as an antivira...
$GILD $RGLS W #HCV #HCC #TumorEnvironment *Hepatocellular Carcinoma Decreases the Chance of Successful Hepatitis C Vi...
This article willfully misleads, Alley. First, it's trying to depict its agent as a prodrug of tenofovir and implies Gil...
$RGLS On Wednesday the NYT published, "Are New Drugs for Hepatitis C Safe? A Report Raises Concerns: https://www.nyt...
A phase 1b of RG-101 was published in The Lancet recently: "Safety, tolerability, and antiviral effect of RG-101 in p...
This abstract more than likely moving RGLS of late. Background and aims: MicroRNA (miR)-122 is the most abundant mi...
$GILD Very interesting... Here we describe a patient with advanced follicular lymphoma and concurrent hepatitis C vi...
Would like to present a company here that has been on a tear the last 5 days and has 2 drugs targeting HEP B and shingle...
$ARWR $AMGN #HBV - An interesting article published this morning "Arrowhead: Two Collaborations in One Week" Rece...
$ARWR np - Arrowhead Pharmaceuticals Doses First Patient with Hepatitis B in Multiple Ascending Dose Portion of Phase 1...
'twas me that asked you the question! And after reading your opinion, I shall scratch it off my watch list forthwith. Th...
$PTN - I don't believe the conspiracy theory that Feuerstein shorts stocks and then writes about them. But I do think a ...
There was a piece on ReachMD some years back when it was on XM satellite about a researcher at LSU who was going out wit...
$BCRX BioCryst has an approved antiviral that knocks out swine, bird, Zika and most flus in the ICU. Also approved in Ja...
Tough but not mean. My rules wouldn't apply in your case as you're being legitimately rx'd a controlled substance, which...
$ARWR - Arrowhead Pharmaceuticals Presents Promising ARC-520 Hepatitis B Data at The International Liver Congress(TM) 20...
Yes, agree, 18 months is a very long time when the virus in question is a labile RNA virus. Not an eternity, but certain...
From France, a Phase II HIV Antiviral with Promising Results #ABX464 #Abivax #CGIB: https://t.co/Z6TrnC6Pe5 image: h...
A small Australian company Nanosonics (ASX:NAN) has developed infection control/ decontamination procedure for ultrasoun...
Thought this may be of interest to some. Stock rose just over 120% today. ContraVir Pharmaceuticals, Inc. (NASDAQ: CTR...
Arrowhead's HBV data is out for single doses. Somewhat as expected the antiviral efficacy is not as high as I would've l...
ARWR- Arrowhead Reports Peak Reduction in HBsAg of Up to 99% (1.9 log) After a Single Dose with Hepatitis B Candidate AR...
There is a portion of the virus that is conserved during its mutations. Otherwise, it ceases to be a virus. By targeting...
TLOG starting over: The company intends to initiate a combination single ascending dose/multiple ascending dose clin...
I tend to doubt we will see MERS action here. First, half of all South Korean cases are traceable to one facility. Next,...
$INO: FWIW: Doc KSS comments were "prospects are so bad I have a hard time seeing how it can continue at all". Somehow I...
FYI even dirk has turned on Benitec... http://www.biocqr.com/#!rss-feeds/c2t8 Time is running out for Benitec Benite...
Well Cyndy, I think you'd agree that we need both natural healing agents AND modern pharmaceuticals! I think the problem...
Hi Stephen: There just isn't clinical evidence that vitamin D use leads to coronary calcification. It's been looked for...
Robert - Re PETX – (Aratana Therapeutics ) Chart looks like it starting to form a “cup and handle” pattern. It ha...
Since January 2014, a total of 1107 patients have started antiviral treatment. Among genotype 1 patients, 60% were treat...
CMRX - Chimerix This is a nice chart. From 14 to 35 in the last year. Working on an Ebola treatment. Chimerix's ...
So they studied a mere 34 patients with mild disease, and this makes it into NEJM? Very dismaying. An Interferon-fr...
SA Breaking News (Sunday 5:06 pm): Achillion presents HCV data at The Liver Meeting • 5:06 PM At this week's Annual ...
It's a fair question...about $ARWR. I got hold of the abstract on 8 October. Michael Yee of RBC Capital or one of his as...
Duncan's surviving son and brother contend in their suit against the Dallas hospital that Duncan received no form of inv...
Dr. KSS and fellow gummies - an interesting presentation by the UC San Diego AntiViral Research Center on infectious dis...
William...yes, what you are describing is a customary angle on antiviral drug design, A "silent mutation" isn't really s...
Doc KSS or anyone who may have stumbled across this; Have you ever heard of or what do you know about REPLICor? htt...
Doesn't matter.....this is for the old form of tenofovir: TDF. The newer form, TAF, has better antiviral activity and pe...
Thank you, Dr. KSS. I think you are exactly right on. I am holding BioCryst (BCRX), but not for its Ebola antiviral....
To Jack Weiss: I am in no way a supporter of milkthistle/silymarin use. It is not that it has not been proven to be of b...
Hi Doug: glad you are here and thanks for posting. Stick around. It's hard for me to see NNVC ever going anywhere. It...
KennyG: I have taken to completely ignoring Pannobhaso because he gets so very much so very wrong. The Tribetarna trial ...
Here's an interesting situation: NovaBay Pharm (NBY) is a $40 million company in California that is developing a novel c...
Dr, KSS - RE Marburg and Ebola, BioCryst (BIOC) has an antiviral for most (all?) hemmoraigic fevers in animal trials. No...
I believe the truth is somewhere between the medical doctors who belittle alternative or complimentary health care, and ...
Diana: to me that is definitely a risk. And while chlorination is reasonably antibacterial, its antifungal and antiviral...
HEB's Aferon(R) N shows anti-MERS activity in vitro. http://www.investorvillage.com/smbd.asp?mb=270&mn=232&pt=msg&mid=1...
Frank: there are some physician message boards, and just during the weekend, hints are being dropped that Alferon has be...
gumshoegabby: I agree; the most successful antiviral therapy is immunizations; the problem is how to help the body find ...
FYI: LA JOLLA, Calif., March 5, 2014 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical comp...
I have no position but its nice to see the space get recognition. I have the full report but weary of posting. Arr...
This is a safety concern with the FDA (and EMEA) as there is no off switch. This is one reason why therapeutic vaccines ...
Biocqr: Milkthistle is silymarin ("silly," get it?). I would not be caught dead recommending this nonsense and would ost...
It is frankly difficult for me to get interested in NNVC (Nanoviricides). Its agents are sequestrants, partitioners. Vir...
I would be curious to hear KSS's take on NNVC... NanoViricides, Inc. (www.nanoviricides.com) is a development stage c...
You are quite right George. In the days before DAA's for HCV, the single best and most potent interferon-alfa (consensus...
JJ: Thanks for your comment. You are quite right about M. Graham. The specific guy who designed TT-034 with its three sh...